Excellence Research Publishes Comprehensive Global Report on the Remote Neurological Monitoring Market

Excellence Research projects the remote neurological monitoring market will grow from USD 2.52 billion in 2026 to USD 6.27 billion by 2033 at 13.9% CAGR.

Excellence Research Publishes Comprehensive Global Report on the Remote Neurological Monitoring Market, Projecting Growth from USD 2.52 Billion in 2026 to USD 6.27 Billion by 2033

Global remote neurological monitoring market forecast to expand at a 13.9% CAGR across 60+ countries, driven by rising neurological disease burden and accelerating adoption of AI-enabled continuous monitoring technologies.

Request a free sample of this report to explore detailed insights.Get Free Sample Here

Wilmington, Delaware, July 14, 2025. Excellence Research has announced the official publication of its latest market intelligence title, "Remote Neurological Monitoring Market Size, Share, Trends and Forecast 2026 to 2033." The report delivers granular analysis of a market that stood at USD 2.52 billion in 2026 and is projected to reach USD 6.27 billion by 2033, advancing at a compound annual growth rate of 13.9% throughout the forecast period. The study spans more than 60 countries across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, offering one of the most geographically comprehensive assessments of this sector published to date.

The market is being propelled by a convergence of structural forces that are reshaping how neurological conditions are detected, tracked, and managed outside traditional clinical settings. The global prevalence of epilepsy alone affects approximately 50 million people worldwide, according to World Health Organization estimates, while stroke, Parkinson's disease, and traumatic brain injury collectively generate an enormous and underserved demand for continuous remote monitoring. Reimbursement policy shifts in the United States, particularly expanded Medicare coverage for remote patient monitoring codes introduced in recent years, have meaningfully reduced the financial barriers that historically slowed adoption among ambulatory care providers. Simultaneously, miniaturized sensor hardware and cloud-based analytics platforms have made it technically feasible for patients to transmit high-fidelity neurological data from their homes without clinical supervision.

The report identifies several findings that challenge the prevailing assumption that hospital-based neurology departments will remain the primary growth engine for this market. Outpatient neurology clinics and home health settings in Germany, South Korea, and Australia are recording faster adoption rates than major academic medical centers in those same countries, a trend that reflects both cost pressure on inpatient infrastructure and patients' preference for monitoring that integrates with daily life. The report also identifies pediatric epilepsy monitoring as a disproportionately fast-growing application segment, with demand for pediatric-specific wearable EEG devices outpacing adult equivalents in several high-income markets. On the technology side, AI-driven seizure detection algorithms embedded within implantable neurostimulators, particularly the NeuroPace RNS System approved by the U.S. Food and Drug Administration, are elevating the standard of care and raising competitive pressure on traditional long-term EEG systems supplied by companies such as Natus Medical and Compumedics.

The competitive analysis section of the report profiles eight leading companies in depth: Medtronic, NeuroPace, Natus Medical, Compumedics, Masimo, Philips, GE HealthCare, and BioSerenity. Medtronic continues to hold significant leverage through its implantable cardiac and neurological monitoring device portfolio, though the company faces intensifying competition from BioSerenity, a Paris-based firm whose wearable EEG garments have gained regulatory clearance in Europe and are expanding into U.S. hospital networks. Masimo's foray into neurological monitoring, building on its established pulse oximetry infrastructure, represents a lateral integration strategy that incumbent pure-play neuro monitoring vendors will need to address directly over the next two to three years. Philips and GE HealthCare retain strong positions in hospital-based neurophysiology systems, but both face margin pressure as cloud-native competitors offer subscription-based remote monitoring platforms at significantly lower capital expenditure thresholds.

"The remote neurological monitoring sector is at an inflection point that most investors and procurement teams have not fully priced in," said Dr. Olivia Hartmann, Principal Analyst at Excellence Research. "The market's 13.9% CAGR is not simply a reflection of device proliferation. It reflects a fundamental restructuring of where neurological care is delivered and who pays for it. The companies that will capture disproportionate share through 2033 are those combining validated clinical algorithms with patient-friendly hardware and seamless integration into electronic health record systems. That combination is still rare, which means consolidation activity among mid-tier players is likely to accelerate well before the end of this decade."

The full report is available for immediate purchase through the Excellence Research website. Licensing options are structured to accommodate organizations of varying sizes. A single-user license is priced at USD 4,500. A multi-user license, suitable for teams of up to five researchers or analysts, is available at USD 6,500. Organizations requiring enterprise-wide access may purchase a corporate license at USD 8,600, which includes unlimited internal distribution rights and one complimentary analyst consultation session.

About Excellence Research

Excellence Research is a global market intelligence firm headquartered in Wilmington, Delaware. The firm produces primary and secondary research across healthcare, technology, energy, and consumer sectors, serving clients that include Fortune 500 corporations, private equity funds, and government agencies across more than 40 countries. Excellence Research is committed to delivering actionable, data-driven insight that supports strategic decision-making at the highest organizational levels.

Media Contact: